These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8872485)

  • 1. The endogenous pathway of MHC class II antigen presentation.
    Lechler R; Aichinger G; Lightstone L
    Immunol Rev; 1996 Jun; 151():51-79. PubMed ID: 8872485
    [No Abstract]   [Full Text] [Related]  

  • 2. Processing and presentation of endocytically acquired protein antigens by MHC class II and class I molecules.
    German RN; Castellino F; Han R; Reis e Sousa C; Romagnoli P; Sadegh-Nasseri S; Zhong GM
    Immunol Rev; 1996 Jun; 151():5-30. PubMed ID: 8872483
    [No Abstract]   [Full Text] [Related]  

  • 3. Transcriptional regulation of the MHC class II antigen presentation pathway.
    Boss JM; Jensen PE
    Curr Opin Immunol; 2003 Feb; 15(1):105-11. PubMed ID: 12495741
    [No Abstract]   [Full Text] [Related]  

  • 4. Major histocompatibility complex (MHC) class I and class II proteins: impact of polymorphism on antigen presentation.
    Abualrous ET; Sticht J; Freund C
    Curr Opin Immunol; 2021 Jun; 70():95-104. PubMed ID: 34052735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in MHC class I molecules influence their interactions with components of the antigen processing and presentation pathway.
    Aflalo A; Boyle LH
    Int J Immunogenet; 2021 Aug; 48(4):317-325. PubMed ID: 34176210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen processing and recognition.
    Harding CV; Neefjes J
    Curr Opin Immunol; 2005 Feb; 17(1):55-7. PubMed ID: 15653311
    [No Abstract]   [Full Text] [Related]  

  • 7. Introducing endogenous antigens into the major histocompatibility complex (MHC) class II presentation pathway. Both Ii mediated inhibition and enhancement of endogenous peptide/MHC class II presentation require the same Ii domains.
    Frauwirth K; Shastri N
    Immunology; 2001 Apr; 102(4):405-15. PubMed ID: 11328374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The classical dichotomy between presentation of endogenous antigens via the MHC class I pathway and exogenous antigens via the MHC class-II pathway.
    Kyewski B; Haskins K
    Curr Opin Immunol; 2012 Feb; 24(1):67-70. PubMed ID: 22305303
    [No Abstract]   [Full Text] [Related]  

  • 9. Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison.
    Storni T; Bachmann MF
    J Immunol; 2004 May; 172(10):6129-35. PubMed ID: 15128799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
    Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
    J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.
    Watts C
    Nat Immunol; 2004 Jul; 5(7):685-92. PubMed ID: 15224094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy in MHC class II antigen processing.
    Strawbridge AB; Blum JS
    Curr Opin Immunol; 2007 Feb; 19(1):87-92. PubMed ID: 17129719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of subcellular organelles involved in major histocompatibility complex (MHC) class II-restricted antigen presentation by electrophoresis.
    Engering A; Lefkovits I; Pieters J
    Electrophoresis; 1997 Dec; 18(14):2523-30. PubMed ID: 9527480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.
    Carstens C; Newman DK; Bohlen H; König A; Koch N
    Int Immunol; 2000 Nov; 12(11):1561-8. PubMed ID: 11058576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity.
    Armstrong TD; Clements VK; Martin BK; Ting JP; Ostrand-Rosenberg S
    Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6886-91. PubMed ID: 9192661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation.
    Anderson HA; Hiltbold EM; Roche PA
    Nat Immunol; 2000 Aug; 1(2):156-62. PubMed ID: 11248809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy in MHC class II presentation: sampling from within.
    Menéndez-Benito V; Neefjes J
    Immunity; 2007 Jan; 26(1):1-3. PubMed ID: 17241953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of antigen processing].
    Murata S
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():287-92. PubMed ID: 15861670
    [No Abstract]   [Full Text] [Related]  

  • 19. How the codfish changed its immune system.
    Parham P
    Nat Genet; 2016 Sep; 48(10):1103-4. PubMed ID: 27681288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bio-logical role of invariant chain (Ii) in MHC class II antigen presentation.
    Nordeng TW; Bakke O
    Immunol Lett; 1994 Dec; 43(1-2):47-55. PubMed ID: 7737689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.